(CNN) -- A weekly dose of semaglutide, the key ingredient in blockbuster medications Ozempic and Wegovy, helped seven out of 10 patients newly diagnosed with type 1 diabetes stop taking insulin after ...

GLP-1 drugs like Ozempic and Mounjaro have significant health benefits for type 1 diabetes, including weight loss, despite ...

Once-weekly semaglutide 1 mg was tied to a reduction in total daily insulin dose among adults with type 1 diabetes, ...

BUFFALO, N.Y.— Treating newly diagnosed Type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin.

Treatment with the diabetes and weight loss drug semaglutide may allow people newly diagnosed with Type 1 diabetes to dramatically cut back or even completely stop insulin injections, a very small ...

Type 2 diabetes, linked to insulin resistance, affects a significant portion of the American population, many undiagnosed. Pre-diabetes, also caused by insulin resistance, often progresses to Type 2 ...

A 26-week trial reveals that metformin, long viewed as a promising add-on therapy, lowers insulin needs but leaves tissue-level insulin resistance unchanged. Study: Effect of metformin on insulin ...